LINE (LINEAGE CELL THERAPEUTICS IN) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold LINE (LINEAGE CELL THERAPEUTICS IN) with a combined value of $11.58M across 6,932,073 shares. The largest holder is BlackRock, Inc. with a position worth $6.40M (0.00% of their portfolio). 4 funds increased their holdings.
Total Institutional Value
$11.58M
Total Shares Held
6,932,073
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $6.40M | 0.00% | +71.9% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $4.02M | 0.01% | +26.2% |
| 3 | CITADEL ADVISORS LLC | $891.37K | 0.00% | +60.3% |
| 4 | Point72 Asset Management, L.P. | $266.21K | 0.00% | +0.0% |